Publication dates

Cancer Immunotherapy Industry, October 2014 Market Research & Statistics

You might be interested in: vaccine, life sciences

1-10 of about 200 reports for Cancer Immunotherapy

Pathology Description in Europe

  • Media Release
  • October 2014
    12 pages
  • Pathology  

  • Europe  

    United States  

    Switzerland  

View report >

Pathology Description in Europe

  • Investor Update
  • October 2014
    23 pages
  • Pathology  

    Pharmaceutical  

  • Europe  

    United States  

    Japan  

View report >

Pathology Industry - Investor Report, April 2014

  • Innovative Science Affordable Medicine
  • April 2014
    48 pages
  • Insulin  

    Biosimilars  

  • India  

    World  

View report >

Selvita - Annual Report, October 2014

  • Corporate Presentation
  • October 2014
    33 pages
  • Poland  

    United States  

    Europe  

View report >

Pathology Description in the US - Forecast

  • In this Issue
  • January 2013
    17 pages
  • Cancer  

  • United States  

View report >

Takara Holdings Incorporated - Annual Report, 2013

  • Excellence, Future of Innovation
  • January 2013
    68 pages
  • Japan  

View report >

Ucb - Annual Report, 2013

  • Http://www.edgar-online.com
  • January 2013
    137 pages
  • Equity Market  

    Therapeutics  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Introduction: Oncology Special Edition
  • January 2013
    15 pages
  • Cancer  

  • United States  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >

Pathology Description in Europe

  • Background Paper 6.5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >
29 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 6 813)

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.